Please login to the form below

Not currently logged in
Email:
Password:

Mundipharma appoints chief information officer

Philippe Mazas joins the UK-based pharma network from Smith & Nephew

Philippe MazasMundipharma, a global network of privately-owned independent associated pharma companies, has appointed a new chief information officer in the form of Philippe Mazas.

He joins the network with almost 20 years’ experience as a chief information officer and most recently served Smith & Nephew.

His new role will see him take responsibility for the IT services provided to Mundipharma’s global network of associated companies.

Mazas said: “Taking an entrepreneurial approach to technology is vital for pharma companies that want to stay ahead of the every advancing pace of digital transformation.

“My goal is to ensure that the Mundipharma network has the technology support it needs to lead the charge in pharma by being customer focused, value driven and business led.

“This approach will enable us to be more efficient and nimble, while ensuring the Mundipharma network continues to advance technology to aid in the development and commercialisation of medicines that address patients’ needs.”

5th January 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics